Latest biopharmaceutical Stories
Experimental monoclonal antibody to be used in clinical trials with patients in West Africa infected with the Ebola virus.
The company leverages its keen understanding of protein purification to achieve the highest purification standards and product quality LONDON, Dec.
NEW YORK, Dec.
BIRMINGHAM, Ala. and BATON ROUGE, La. and RALEIGH, N.C. and RESEARCH TRIANGLE PARK, N.C., Dec.
HERZLIYA, Israel, Dec.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had
Led by CSL Behring performance, the company focuses on sustainable business practices, strong results to provide patients with lifesaving, life-enhancing therapies around the world. KING OF
Breadth and depth of leadership and commercial manufacturing experience a strong fit for company's growth and culture SEATTLE, Dec.
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.